Plasma hepatitis C virus (HCV) RNA is comparable to hepatic HCV RNA when obtained while on therapy at the end of treatment as a predictor of sustained response in patients with chronic hepatitis C infection
β Scribed by Lino J. Deguzman; Jose M. Nieto; Shelley A. Deguzman; Andrew Conrad; Bradley Collins
- Book ID
- 119429012
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 176 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzymeβlinked immunosorbent assay based on genotypeβspecific recombinant peptides of the NS4
WHO International Standards for nucleic acid tests are used widely to compare the different assays used in HCV RNA quantitation. The aim of the study was to assess the impact of the international unit standard for measuring HCV RNA in the management of patients with chronic hepatitis C virus (HCV) i